The Vaccine Market was valued at USD 74.80 billion in 2023 and is projected to reach USD 168.69 billion, growing with a CAGR of 10.70% by 2031

The avian influenza vaccines market is expanding at a CAGR of 5.85% crossing USD 196.25 million by 2029 & It is classiffied by vaccine type, application, and strain.

Flu Vaccines Market is thriving a CAGR of 8.90% worth USD 14.83 billion by 2029. Its divided by Influenza Type, Manufacturing Technology, Vaccine Type, Age Group & End User.

The Bacterial Vaccines Market growth at a CAGR of 8.20% & expected USD 36.97 billion by 2029. It is divided as type, route of administration, distribution channel and end-user.

Inactivated Vaccines Market was USD 40,763.4 million in 2022, and it will reach USD 70,564.48 million by 2030, growing at a CAGR of 7.10% during the forecast period.

The Bacterial Vaccines Market growth at a CAGR of 8.20% & expected USD 36.97 billion by 2029. It is divided as type, route of administration, distribution channel and end-user.

The Veterinary-Animal Vaccines Market register at a CAGR of 6.9% & surpass USD 18.23 billion by 2030. It is categorized as type, disease, technology, route of administration.

The recombinant protein vaccines market worth was USD 3.03 million in 2023 & it crosses USD 5.22 million by 2031 experiencing a CAGR of 13.4% by the forecast period.